Cargando…
A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come
The history of biomarkers and ultrasonography dates back over more than 50 years. The present status of biomarkers used in the context of ovarian cancer is addressed. Attention is given to new interpretations of the etiology of ovarian cancer. Cancer antigen 125 (CA125) and multivariate index assays...
Autor principal: | Ueland, Frederick R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373023/ https://www.ncbi.nlm.nih.gov/pubmed/28282875 http://dx.doi.org/10.3390/diagnostics7010014 |
Ejemplares similares
-
Answer Comes from the Ghost of Christmas Past, Present, and Yet to Come
por: Bahn, Geon Ho
Publicado: (2018) -
Spectres of Clock Evolution: Past, Present, and Yet to Come
por: Jabbur, Maria Luísa, et al.
Publicado: (2022) -
ME/CFS: Past, Present and Future
por: Weir, William, et al.
Publicado: (2021) -
A Resident’s Perspective of Ovarian Cancer
por: Smith, Christopher G.
Publicado: (2017) -
The past, present and future of genome-wide re-annotation
por: Ouzounis, Christos A, et al.
Publicado: (2002)